Pursuant to regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Aspira Pathlab & Diagnostics has informed that it enclosed copies of Newspaper advertisement dated 13th November, 2023 for the quarter and half year ended September 30, 2023 Financial Results published in English Newspaper 'Business Standard' and Marathi Newspaper 'Mumbai Lakshdeep’ respectively.
The above information is a part of company’s filings submitted to BSE.